{
    "id": 9510,
    "fullName": "EPHA3 over exp",
    "impact": "none",
    "proteinEffect": "no effect",
    "geneVariantDescriptions": [
        {
            "description": "EPHA3 over exp indicates an over expression of the EphA3 protein. However, the mechanism causing the over expression is unspecified.",
            "references": [
                {
                    "id": 275,
                    "pubMedId": null,
                    "title": "External Reference Not Available (N/A)",
                    "url": "https://ckb.jax.org/about/glossaryOfTerms"
                }
            ]
        }
    ],
    "type": "non-specific",
    "gene": {
        "id": 2042,
        "geneSymbol": "EPHA3",
        "terms": [
            "EPHA3",
            "EK4",
            "ETK",
            "ETK1",
            "HEK",
            "HEK4",
            "TYRO4"
        ]
    },
    "variant": "over exp",
    "createDate": "07/23/2015",
    "updateDate": "11/29/2019",
    "referenceTranscriptCoordinates": null,
    "partnerGenes": [
        
    ],
    "evidence": [
        {
            "id": 15321,
            "approvalStatus": "Clinical Study",
            "evidenceType": "Prognostic",
            "efficacyEvidence": "In multiple clinical studies, overexpression of Epha3 in gastric cancer patients was associated with poor prognosis (PMID: 22350700) and decreased relapse-free survival (PMID: 28465671, PMID: 24908114).",
            "molecularProfile": {
                "id": 9464,
                "profileName": "EPHA3 over exp"
            },
            "therapy": {
                "id": 1776,
                "therapyName": "N/A",
                "synonyms": null
            },
            "indication": {
                "id": 10534,
                "name": "stomach cancer",
                "source": "DOID"
            },
            "responseType": "not applicable",
            "references": [
                {
                    "id": 13074,
                    "pubMedId": 28465671,
                    "title": "High expression of EphA3 (erythropoietin-producing hepatocellular A3) in gastric cancer is associated with metastasis and poor survival.",
                    "url": "http://www.ncbi.nlm.nih.gov/pubmed/28465671"
                },
                {
                    "id": 13076,
                    "pubMedId": 24908114,
                    "title": "Overexpression of Ephrin A2 receptors in cancer stromal cells is a prognostic factor for the relapse of gastric cancer.",
                    "url": "http://www.ncbi.nlm.nih.gov/pubmed/24908114"
                },
                {
                    "id": 13077,
                    "pubMedId": 22350700,
                    "title": "Aberrant expression of EphA3 in gastric carcinoma: correlation with tumor angiogenesis and survival.",
                    "url": "http://www.ncbi.nlm.nih.gov/pubmed/22350700"
                }
            ],
            "ampCapAscoEvidenceLevel": "NA",
            "ampCapAscoInferredTier": "NA"
        },
        {
            "id": 11483,
            "approvalStatus": "Preclinical - Patient cell culture",
            "evidenceType": "Actionable",
            "efficacyEvidence": "In a preclinical study, KB004 increased cytoxicity in an pre-B acute lymphocytic leukemia cell line expressing high levels of EphA3 in culture (PMID: 27922598).",
            "molecularProfile": {
                "id": 9464,
                "profileName": "EPHA3 over exp"
            },
            "therapy": {
                "id": 2954,
                "therapyName": "KB004",
                "synonyms": null
            },
            "indication": {
                "id": 9952,
                "name": "acute lymphoblastic leukemia",
                "source": "DOID"
            },
            "responseType": "sensitive",
            "references": [
                {
                    "id": 9542,
                    "pubMedId": 27922598,
                    "title": "EphA3 as a target for antibody immunotherapy in acute lymphoblastic leukemia.",
                    "url": "http://www.ncbi.nlm.nih.gov/pubmed/27922598"
                }
            ],
            "ampCapAscoEvidenceLevel": "D",
            "ampCapAscoInferredTier": "II"
        },
        {
            "id": 11482,
            "approvalStatus": "Preclinical - Cell line xenograft",
            "evidenceType": "Actionable",
            "efficacyEvidence": "In a preclinical study, cIIIA4 decreased engraftment of pre-B acute lymphoblastic leukemia cells expressing high levels of EphA3 in xenograft models (PMID: 27922598).",
            "molecularProfile": {
                "id": 9464,
                "profileName": "EPHA3 over exp"
            },
            "therapy": {
                "id": 6004,
                "therapyName": "cIIIA4",
                "synonyms": null
            },
            "indication": {
                "id": 9952,
                "name": "acute lymphoblastic leukemia",
                "source": "DOID"
            },
            "responseType": "sensitive",
            "references": [
                {
                    "id": 9542,
                    "pubMedId": 27922598,
                    "title": "EphA3 as a target for antibody immunotherapy in acute lymphoblastic leukemia.",
                    "url": "http://www.ncbi.nlm.nih.gov/pubmed/27922598"
                }
            ],
            "ampCapAscoEvidenceLevel": "D",
            "ampCapAscoInferredTier": "II"
        }
    ],
    "molecularProfiles": [
        {
            "id": 9464,
            "profileName": "EPHA3 over exp",
            "profileTreatmentApproaches": [
                {
                    "id": 14015,
                    "name": "KB004",
                    "profileName": "EPHA3 over exp"
                }
            ]
        }
    ],
    "allTranscriptCoordinates": [
        
    ]
}